Metsera
Highly Engaged Employees
Manufacturing · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3 World Trade Ctr 175, New York City, Ne...Phone Number
(212) 784-6595Website
www.metsera.comRevenue
$26.4 MillionStock Symbol
MTSRIndustry
About Metsera
Metsera Org Chart
Is Metsera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Metsera is spiking on competitors!
Earning: See what the market has to say on Metsera recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Metsera has new funding data
Product Launch: Get notified when Metsera launches new products
Click to see if Metsera had a recent Job posting/layoffs
Check if Metsera has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Metsera
Metsera, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Metsera
Find 3 more new buyers
Company Profile Activity
Activity Insights
Metsera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Metsera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Metsera.
Metsera financials insights
Gather financial insights about Metsera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$290M
Series B
$215M
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Metsera
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs... Read More